Andrew W. Tai
- Molecular Biology top 10%
- Hepatology top 1%
- Epidemiology top 5%
- Cell Biology top 2%
- Infectious Diseases top 5%
- Co-authors
- Ching‐Hwa SungHongliang WangChristian BodeJen-Zen ChuangUwe WolfrumLee F. PengShadi SalloumRamnik J. Xavier
- Topics
- Hepatitis C virus research (13 papers)Hepatitis B Virus Studies (10 papers)SARS-CoV-2 and COVID-19 Research (9 papers)
- Cited by
- HepatologyCell BiologyVirology
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Andrew W. Tai
55 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.2k
- Hepatology 651
- Epidemiology 613
- Cell Biology 609
- Infectious Diseases 351
Countries citing papers authored by Andrew W. Tai
This map shows the geographic impact of Andrew W. Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Tai more than expected).
Fields of papers citing papers by Andrew W. Tai
This network shows the impact of papers produced by Andrew W. Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Tai. The network helps show where Andrew W. Tai may publish in the future.
Co-authorship network of co-authors of Andrew W. Tai
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Tai. A scholar is included among the top collaborators of Andrew W. Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Tai. Andrew W. Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 39 | |
| 3 | 5 | |
| 4 | 37 | |
| 5 | 20 | |
| 6 | 7 | |
| 7 | 41 | |
| 8 | 14 | |
| 9 | 8 | |
| 10 | 16 | |
| 11 | 48 | |
| 12 | 29 | |
| 13 | 5 | |
| 14 | 54 | |
| 15 | 25 | |
| 16 | 15 | |
| 17 | 24 | |
| 18 | 70 | |
| 19 | 8 | |
| 20 | 47 |
About Andrew W. Tai
Andrew W. Tai is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Hepatology (651 citations), Cell Biology (609 citations) and Virology (160 citations). Andrew W. Tai has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Ching‐Hwa Sung, Hongliang Wang, Christian Bode, Jen-Zen Chuang, Uwe Wolfrum, Lee F. Peng, Shadi Salloum, Ramnik J. Xavier, Yair Benita and Naoya Sakamoto. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.